Osenvelt
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Osenvelt, covering 2026-03-19 to 2026-08-13. Get the full timeline:
Most recent: EMA Authorised: Osenvelt (denosumab) — Celltrion Healthcare Hungary Kft.